journal article·2025-10-10

Horizon scanning to shape nanomedicines through researcher–regulator collaboration

Yoana Nuevo, Eva Hemmrich, Rosa Virto, Adela Nuñez, Celia Cerrato, René Thürmer, Diego Alejandro Dri, Scott McNeil, Tomáš Boráň

Nature Reviews Materials· Volume 10· Issue 12
Publisher page

Abstract

No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.

Source: Not provided · Quality: missing

Research context

OpenAlex topics: Advanced Biosensing Techniques and Applications · Advanced biosensing and bioanalysis techniques · Biosensors and Analytical Detection

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (5)

Show source-provided references
1. EMA & HMA. European Medicines Agencies Network Strategy to 2025 - Protecting Public Health at a Time of Rapid Change (EMA & HMA, 2020).
2. Vignali, V., Hines, P. A., Cruz, A. G., Ziętek, B. & Herold, R. Health horizons: future trends and technologies from the European Medicines Agency’s horizon scanning collaborations. Front. Med. 9, 1064003 (2022).10.3389/fmed.2022.1064003 ↗
3. EMA & HMA. EU-IN Horizon Scanning Report: Nanotechnology-Based Medicinal Products for Human Use (EMA & HMA, 2025).
4. Starokozhko, V. et al. Strengthening regulatory science in academia: STARS, an EU initiative to bridge the translational gap. Drug Discov. Today 26, 283–288 (2021).10.1016/j.drudis.2020.10.017 ↗
5. Brown, P. D. & Patel, P. R. Nanomedicine: a pharma perspective. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 7, 125–130 (2015).10.1002/wnan.1288 ↗